Skip to content

Clinical trials

Observational Hematologic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Observational Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20181
20201
20212
20223
20233
20241
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Unknown status6
Not yet recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Zhejiang University3
Institute of Hematology & Blood Diseases Hospital, China3
Peking University People's Hospital3
Peking University First Hospital2
The First Affiliated Hospital of Soochow University2
Affiliated Hospital to Academy of Military Medical Sciences1
Beckman Coulter, Inc.1
Children's Hospital of Fudan University1
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine1
Henan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms24
COVID-192
Hematologic Diseases2
Invasive Fungal Infections2
Lymphoma2
Mucormycosis2
Breast Neoplasms1
Bronchiolitis Obliterans Syndrome1
Esophageal Neoplasms1
Graft vs Host Disease1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.